Silverarc Capital Management’s Guardant Health GH Stock Holding History

Silverarc Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Buy	99,826 +1,312	+1%	+$143K	1.56%	22
2026 Q1	$9.1M	Buy	98,514 +6,600	+7%	+$663K	0.93%	29
2025 Q4	$9.39M	Buy	+91,914	New	+$8.22M	1.3%	26
2021 Q4	–	Sell	-4,218	Closed	-$527K	–	81
2021 Q3	$527K	Sell	4,218 -455	-10%	-$54.1K	0.3%	66
2021 Q2	$580K	Sell	4,673 -5,519	-54%	-$742K	0.26%	77
2021 Q1	$1.56M	Sell	10,192 -8,633	-46%	-$1.3M	0.85%	44
2020 Q4	$2.43M	Buy	+18,825	New	+$2.17M	1.41%	26

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Silverarc Capital Management's GH Position: Q2 2026 in Review

Silverarc Capital Management increased its Guardant Health (GH) stake by 1.3% in Q2 2026, buying an estimated $143K and bringing the position to 99,826 shares worth $15M. The position accounts for 1.56% of the portfolio, ranked #22.

Silverarc Capital Management first reported a position in GH in Q4 2020 and has held it in 7 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Silverarc Capital Management held 99,826 shares of Guardant Health worth $15M as of Q2 2026.
Silverarc Capital Management bought 1,312 Guardant Health shares in Q2 2026, an estimated $143K.
Guardant Health made up 1.56% of Silverarc Capital Management's portfolio in Q2 2026, its #22 holding.
Silverarc Capital Management first reported a position in Guardant Health in Q4 2020 and has held it in 7 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.